J 2020

Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis

KRAJICKOVA, Dagmar, Jiří KRÁL, Roman HERZIG, L'udovit KLZO, Antonin KRAJINA et. al.

Basic information

Original name

Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis

Authors

KRAJICKOVA, Dagmar (203 Czech Republic), Jiří KRÁL (203 Czech Republic, belonging to the institution), Roman HERZIG (203 Czech Republic), L'udovit KLZO (203 Czech Republic), Antonin KRAJINA (203 Czech Republic), Jaroslav HAVELKA (203 Czech Republic), Libor SIMUNEK (203 Czech Republic), Oldrich VYSATA (203 Czech Republic), Tran Van QUANG (203 Czech Republic), Michal BAR (203 Czech Republic) and Martin VALIS (203 Czech Republic, guarantor)

Edition

Scientific Reports, USA, NATURE RESEARCH, 2020, 2045-2322

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30103 Neurosciences

Country of publisher

Germany

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.379

RIV identification code

RIV/00216224:14110/20:00118096

Organization unit

Faculty of Medicine

UT WoS

000609190200007

Keywords in English

cerebral venous sinus thrombosis

Tags

Tags

International impact, Reviewed
Změněno: 2/2/2021 10:36, Mgr. Tereza Miškechová

Abstract

V originále

We aimed was to assess the factors influencing therapy choice and clinical outcome after 3-4 months in patients with cerebral venous sinus thrombosis (CVST). In a retrospective, bi-centric study, the set consisted of 82 consecutive CVST patients (61 females; mean age 33.5 +/- 15.7 years). Following data were collected: baseline characteristics, presence of gender-specific risk factors (GSRF), location and extent of venous sinus impairment, clinical presentation, type of treatment, recanalization, presence of parenchymal lesions, and clinical outcome after 3-4 months (assessed using the modified Rankin Scale [mRS], with excellent outcome defined as mRS 0-1). Multivariate logistic regression analysis was used for statistical evaluation. After 3-4 months, complete recovery was achieved in 41 (50%) and excellent clinical outcome in 67 (81.7%) patients. Female sex (OR 0.11; p=0.0189) and presence of focal neurologic deficit (OR 0.16; p=0.0165) were identified as significant independent negative predictors and, the presence of GSRF (OR 15.63; p=0.0011) as significant independent positive predictor of excellent clinical outcome. In conclusion, in our CVST patients, the presence of GSRF was associated with excellent clinical outcome, while the female sex itself was associated with poorer clinical outcome.